Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
dc.contributor.author | Durdagi, Serdar | en_US |
dc.contributor.author | Randall, Trevor | en_US |
dc.contributor.author | Duff, Henry J | en_US |
dc.contributor.author | Chamberlin, Adam | en_US |
dc.contributor.author | Noskov, Sergei Y | en_US |
dc.date.accessioned | 2014-06-12T19:59:52Z | |
dc.date.available | 2014-06-12T19:59:52Z | |
dc.date.issued | 2014-03-08 | |
dc.description | Article deposited according to publisher policies: http://www.biomedcentral.com/about/copyright June 12, 2014 | en_US |
dc.description.refereed | Yes | en_US |
dc.description.sponsorship | Funding provided by the Open Access Authors Fund | en_US |
dc.identifier.citation | Durdagi et al.: Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity. BMC Pharmacology and Toxicology 2014 15:14. doi:10.1186/2050-6511-15-14 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/35116 | |
dc.identifier.uri | http://hdl.handle.net/1880/50021 | |
dc.language.iso | eng | en_US |
dc.publisher | BioMed Central | en_US |
dc.publisher.corporate | University of Calgary | en_US |
dc.publisher.faculty | Science | en_US |
dc.publisher.url | http://www.biomedcentral.com/2050-6511/15/14 | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity | en_US |
dc.type | journal article | |
thesis.degree.discipline | Biological Sciences | en_US |